» Articles » PMID: 10473124

Two Distinct Subgroups of Group B Sox Genes for Transcriptional Activators and Repressors: Their Expression During Embryonic Organogenesis of the Chicken

Overview
Journal Mech Dev
Publisher Elsevier
Date 1999 Sep 3
PMID 10473124
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Group B Sox genes, Sox1, -2 and -3 are known to activate crystallin genes and to be involved in differentiation of lens and neural tissues. Screening of chicken genomic sequences for more Group B Sox genes identified two additional genes, Sox14 and Sox21. Proteins encoded by Sox14 and Sox21 genes are similar to each other but distinct from those coded by Sox1-3 (subgroup B1) except for the HMG domain and Group B homology immediately C-proximal of the HMG domain. C-terminal domains of SOX21 and SOX14 proteins function as strong and weak repression domains, respectively, when linked to the GAL4 DNA binding domain. These SOX proteins strongly (SOX21) or moderately (SOX14) inhibited activation of delta1-crystallin DC5 enhancer by SOX1 or SOX2, establishing that Sox14 and Sox21 are repressing subgroup (B2) of Group B Sox genes. This provides the first evidence for the occurrence of repressor SOX proteins. Activating (B1) and repressing (B2) subgroups of Group B Sox genes display interesting overlaps of expression domains in developing tissues (e.g. optic tectum, spinal cord, inner ear, alimentary tract, branchial arches). Within each subgroup, most expression domains of Sox1 and -3 are included in those of Sox2 (e.g. CNS, PNS, inner ear), while co-expression of Sox14 and Sox21 occurs in highly restricted sites of the CNS, with the likely temporal order of Sox21 preceding Sox14 (e.g. interneurons of the spinal cord). These expression patterns suggest that target genes of Group B SOX proteins are finely regulated by the counterbalance of activating and repressing SOX proteins.

Citing Articles

Congenital microcoria deletion in mouse links Sox21 dysregulation to disease and suggests a role for TGFB2 in glaucoma and myopia.

Erjavec E, Angee C, Hadjadj D, Passet B, David P, Kostic C Am J Hum Genet. 2024; 111(10):2265-2282.

PMID: 39293448 PMC: 11480854. DOI: 10.1016/j.ajhg.2024.08.019.


Sox21 homeologs autoregulate expression levels to control progression through neurogenesis.

Damuth D, Cunningham D, Silva E Genesis. 2024; 62(4):e23612.

PMID: 39054872 PMC: 11584151. DOI: 10.1002/dvg.23612.


Molecular Basis of Cell Reprogramming into iPSCs with Exogenous Transcription Factors.

Kondoh H Results Probl Cell Differ. 2024; 72:193-218.

PMID: 38509259 DOI: 10.1007/978-3-031-39027-2_11.


SUMO-dependent transcriptional repression by Sox2 inhibits the proliferation of neural stem cells.

Marelli E, Hughes J, Scotting P PLoS One. 2024; 19(3):e0298818.

PMID: 38507426 PMC: 10954124. DOI: 10.1371/journal.pone.0298818.


SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma.

Bae S, Lee K, Han S, Yun C, Park C, Jang H Cells. 2024; 13(3.

PMID: 38334608 PMC: 10854781. DOI: 10.3390/cells13030216.